Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach (NCT06850025) | Clinical Trial Compass
RecruitingNot Applicable
Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach
France180 participantsStarted 2025-02-25
Plain-language summary
The first objective of H3Sensing is to investigate outdoor environmental, building, dwelling, situational, and behavioral determinants of objectively assessed personal heat stress over daily movements during warm periods.
The second aim is to investigate how these heat stress determinants and momentary and cumulated heat stress itself are related to physiological indicators of heat stress, sleep, thermal discomfort, and well-being.
Who can participate
Age range
30 Years – 64 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Person aged between 30-64 years
* Person living in the Ile-de-France
Exclusion Criteria:
* Person subject to a legal protection measure (safeguarding of justice, curatorship, guardianship)
* Person deprived of liberty by a judicial or administrative decision,
* Person with a major functional limitation affecting their spatial mobility
* Person unable to complete a questionnaire
* Known cardiovascular (other than hypertension) or cerebrovascular disease: personal history of myocardial infarction, rhythm disorders or stroke
* People wearing a pacemaker or other implanted device, due to the risk of interference
* Pregnant or breastfeeding woman
* Person working night or shift
* Person with a definite plan to move in the coming months (before the second collection during summer)
* Person who initially refuses to participate in this second wave of the study
* Person working outside the Ile de France
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Ambulatory blood pressure
Timeframe: Measurement over 4 days, in two separate waves of 4 days
2
Skin temperature
Timeframe: Measurement over 4 days, in two separate waves of 4 days
3
Accelerometry outcomes: total sleep time, sleep efficiency, and wake after sleep onset
Timeframe: These outcomes are collected for 5 successive nights in each of the two periods.
Trial details
NCT IDNCT06850025
SponsorInstitut National de la Santé Et de la Recherche Médicale, France